| Literature DB >> 35410349 |
Przemysław Racewicz1, Michał Majewski2, Hanna Biesiada2, Sebastian Nowaczewski2, Jarosław Wilczyński3, Danuta Wystalska3, Magdalena Kubiak4, Marcin Pszczoła5, Zofia E Madeja5.
Abstract
A global increase in the populations of drug resistant bacteria exerts negative effects on animal production and human health. Our study has been focused on the assessment of resistance determinants in relation to phenotypic resistance of the 74 commensal E. coli isolates present in different ecological environments. The samples were collected from poultry litter, feces, and neck skin. Among the microorganisms isolated from the poultry litter (group A), the highest resistance was noted against AMP and DOX (100%). In the E. coli extracts from the cloacal swabs (group B), the highest resistance was observed against AMP (100%) and CIP (92%). The meat samples (group C) were characterized by resistance to AMP (100%) and STX (94.7%). Genes encoding resistance to β-lactams (blaTEM, blaCTX-M), fluoroquinolones (qnrA, qnrB, qnrS), aminoglycosides (strA-strB, aphA1, aac(3)-II), sulfonamides (sul1, sul2, sul3), trimethoprim (dfr1, dfr5, dfr7/17) and tetracyclines (tetA, tetB) were detected in the studied bacterial isolates. The presence of class 1 and 2 integrons was confirmed in 75% of the MDR E. coli isolates (plasmid DNA), of which 60% contained class 1 integrons, 15% contained class 2 integrons, and 11.7% carried integrons of both classes. Thus, it may be concluded that integrons are the common mediators of antimicrobial resistance among commensal multidrug resistant Escherichia coli at important stages of poultry production.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35410349 PMCID: PMC9001716 DOI: 10.1038/s41598-022-09996-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1The percentage of phenotypic resistance to 6 antibiotics among the MDR E. coli isolates obtained from poultry litter (Group A), cloacal swabs (Group B) and poultry meat (Group C): AMP—Ampicillin; AMC—Amoxycyline with Clavulanic Acid; CIP—Ciprofloxacin; GEN -Gentamicine; STX—Sulfamethoxazole with Trimetoprime; DOX—Doxycycline.
Resistance profiles of multi-drug resistant E. coli isolates.
| Group | Resistance to 3 antibiotics/chemotherapeutics | Resistance to 4 antibiotics/chemotherapeutics | Resistance to 5 antibiotics/chemotherapeutics | Resistance to 6 antibiotics/chemotherapeutics |
|---|---|---|---|---|
| No. of | ||||
| A | 1 | 7 | 7 | 1 |
| B | 1 | 8 | 10 | 6 |
| C | 5 | 8 | 4 | 2 |
| Total | 7 (11,7%) | 23 (38,3%) | 21 (35%) | 9 (15%) |
The prevalence of the resistance genes among multidrug resistant E. coli isolates obtained from poultry litter (Group A), cloacal swabs (Group B) and poultry meat (Group C).
| No. of MDR isolates | Number of MDR isolates resistant to a specific antibiotic | Number of MDR isolates where specific resistance genes have been reported | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMP | AMC | CIP | GEN | STX | DOX | ||||||||||||||||||||||
| Group A | n | 16 | 16 | 12 | 13 | 2 | 13 | 16 | 16 | 0 | 0 | 0 | 1 | 4 | 2 | 9 | 4 | 0 | 8 | 3 | 4 | 6 | 6 | 2 | 12 | 6 | 0 |
| % | 100 | 75 | 81.3 | 12.5 | 81.3 | 100 | 100 | 0 | 0 | 0 | 6.3 | 25 | 12.5 | 56.3 | 25 | 0 | 50 | 18.8 | 25 | 37.5 | 37.5 | 12.5 | 75 | 37.5 | 0 | ||
| Group B | n | 25 | 25 | 22 | 23 | 9 | 21 | 22 | 25 | 1 | 0 | 0 | 1 | 4 | 3 | 14 | 1 | 4 | 7 | 11 | 7 | 15 | 0 | 4 | 13 | 9 | 0 |
| % | 100 | 88 | 92 | 36 | 84 | 88 | 100 | 4 | 0 | 0 | 4 | 16 | 12 | 56 | 4 | 16 | 28 | 44 | 28 | 60 | 0 | 16 | 52 | 36 | 0 | ||
| Group C | n | 19 | 19 | 8 | 15 | 7 | 18 | 13 | 12 | 0 | 0 | 1 | 5 | 2 | 1 | 3 | 2 | 0 | 6 | 5 | 2 | 5 | 2 | 0 | 6 | 2 | 0 |
| % | 100 | 42.1 | 78.9 | 36.8 | 94.7 | 68.4 | 63.2 | 0 | 0 | 5.3 | 26.3 | 10.5 | 5.3 | 15.8 | 10.5 | 0 | 31.6 | 26.3 | 10.5 | 23.3 | 10.5 | 0 | 31.6 | 10.5 | 0 | ||
| Total | n | 60 | 60 | 42 | 51 | 18 | 52 | 51 | 53 | 1 | 0 | 1 | 7 | 10 | 6 | 26 | 7 | 4 | 21 | 19 | 13 | 26 | 8 | 4 | 31 | 17 | 0 |
| % | 100 | 70 | 85 | 30 | 86.7 | 85 | 83.3 | 1.7 | 0 | 1.7 | 11.7 | 16.7 | 10 | 43.3 | 11.7 | 6.7 | 35 | 31.7 | 21.7 | 43.3 | 13.3 | 6,7 | 51.7 | 28.3 | 0 | ||
Figure 2The prevalence of resistance genes among the MRD resistant E. coli isolates obtained from poultry litter (Group A), cloacal swabs (Group B) and poultry meat (Group C).
Phenotypes, antibiotic resistance and prevalence of class 1 and 2 integrons and their resistance gene cassettes in MDR E. coli isolates obtained from poultry litter. (Group A).
| Phenotype of resistance | Mechanisms of resistance | Detection of | Genes included in cassettes | Detection of | Genes included in cassettes |
|---|---|---|---|---|---|
| Resistance genes detected | |||||
| AMP, AMC, CIP, GEN, STX, DOX | + | ||||
| AMP, AMC, CIP, STX, DOX | + | ||||
| AMP, AMC, CIP, STX, DOX | + | ||||
| AMP, AMC, CIP, STX, DOX | + | ||||
| AMP, AMC, CIP, STX, DOX | + | ||||
| AMP, AMC, CIP, STX, DOX | + | ||||
| AMP, AMC, CIP, STX, DOX | |||||
| AMP, AMC, CIP, STX, DOX | |||||
| AMP, AMC, STX, DOX | + | ||||
| AMP, CIP, STX, DOX | + | ||||
| AMP, CIP, STX, DOX | + | ||||
| AMP, CIP, STX, DOX | + | ||||
| AMP, AMC, CIP, DOX | |||||
| AMP, AMC, CIP, DOX | |||||
| AMP, AMC, GEN, DOX | |||||
| AMP, STX, DOX | + |
Phenotypes, antibiotic resistance and prevalence of class 1 and 2 integrons, detected in 25 MDR E. coli isolates obtained from cloacal swabs (Group B).
| Phenotype of resistance | Mechanisms of resistance | Detection of | Genes included in cassettes | Detection of | Genes included in cassettes |
|---|---|---|---|---|---|
| Resistance genes detected | |||||
| AMP, AMC, CIP, GEN, STX, DOX | + | + | |||
| AMP, AMC, CIP, GEN, STX, DOX | + | + | |||
| AMP, AMC, CIP, GEN, STX, DOX | + | ||||
| AMP, AMC, CIP, GEN, STX, DOX | + | ||||
| AMP, AMC, CIP, GEN, STX, DOX | + | + | |||
| AMP, AMC, CIP, GEN, STX, DOX | + | ||||
| AMP, AMC, CIP, STX, DOX | + | ||||
| AMP, AMC, CIP, STX, DOX | + | ||||
| AMP, AMC, CIP, STX, DOX | + | ||||
| AMP, AMC, CIP, STX, DOX | + | + | |||
| AMP, AMC, CIP, STX, DOX | |||||
| AMP, AMC, CIP, STX, DOX | |||||
| AMP, AMC, CIP, STX, DOX | |||||
| AMP, AMC, CIP, STX, DOX | |||||
| AMP, AMC, CIP, GEN, DOX | + | ||||
| AMP, AMC, CIP, GEN, DOX | |||||
| AMP, AMC, CIP, STX | + | ||||
| AMP, AMC, CIP, STX | |||||
| AMP, AMC, CIP, STX | |||||
| AMP, AMC, CIP, DOX | |||||
| AMP, AMC, STX, DOX | + | ||||
| AMP, CIP, STX, DOX | + | ||||
| AMP, CIP, STX, DOX | |||||
| AMP, CIP, STX, DOX | + | ||||
| AMP, AMC, DOX |
Phenotypes, antibiotic resistance and prevalence of class 1 and 2 integrons, detected in 19 MDR E. coli isolates obtained from meat (Group C).
| Phenotype of resistance | Mechanisms of resistance | Detection of | Genes included in cassettes | Detection of | Genes included in cassettes |
|---|---|---|---|---|---|
| Resistance genes detected | |||||
| AMP, AMC, CIP, GEN, STX, DOX | + | ||||
| AMP, AMC, CIP, GEN, STX, DOX | + | + | |||
| AMP, AMC, CIP, STX, DOX | + | ||||
| AMP, AMC, CIP, STX, DOX | + | + | |||
| AMP, CIP, GEN, STX, DOX | + | ||||
| AMP, CIP, GEN, STX, DOX | + | ||||
| AMP, AMC, STX, DOX | + | + | |||
| AMP, AMC, STX, DOX | + | ||||
| AMP, CIP, STX, DOX | + | ||||
| AMP, CIP, STX, DOX | + | ||||
| AMP, CIP, STX, DOX | |||||
| AMP, CIP, STX, DOX | |||||
| AMP, AMC, CIP, STX | |||||
| AMP, AMC, CIP, GEN | |||||
| AMP, CIP, STX | + | ||||
| AMP, CIP, STX | |||||
| AMP, CIP, STX | |||||
| AMP, STX, DOX | + | ||||
| AMP, GEN, STX |
Primer pairs used for PCR analyses in this study.
| Group of antibiotics | Target gene | Primer sequence | Product length (bp) | Reference | |
|---|---|---|---|---|---|
| beta-lactams | F | CTTTATCGGCCCTCACTCAA | 237 | Fang et al.[ | |
| R | AGGTGCTCATCATGGGAAAG | ||||
| F | CGCCGCATACACTATTCTCAGAATGA | 445 | |||
| R | ACGCTCACCGGCTCCAGATTTAT | ||||
| F | ATGTGCAGYACCAGTAARGTKATGGC | 593 | |||
| R | TGGGTRAARTARGTSACCAGAAYCAGCGG | ||||
| F | ACACAATACATATCAACTTCGC | 813 | |||
| R | AGTGTGTTTAGAATGGTGATC | ||||
| Fluoroquinolones | F | ATTTCTCACGCCAGGATTTG | 529 | Marti et al.[ | |
| R | GCAGATCGGCATAGCTGAAG | ||||
| F | GGMATHGAAATTCGCCACTG | 429 | |||
| R | TTYGCBGYYCGCCAGTCGAA | ||||
| F | GACGTGCTAACTTGCGTGAT | 393 | |||
| R | TGGCATTGTTGGAAACTTG | ||||
| Aminoglycosides | F | ATGGTGGACCCTAAAACTCT | 893 | Kozak et.al.[ | |
| R | CGTCTAGGATCGAGACAAAG | ||||
| F | ATGGGCTCGCGATAATGTC | 600 | Kozak et.al.[ | ||
| R | CTCACCGAGGCAGTTCCAT | ||||
| F | ATATCGCGATGCATACGCGG | 877 | Hu et al.[ | ||
| R | GACGGCCTCTAACCGGAAGG | ||||
| Sulfonamides | F | CGGCGTGGGCTACCTGAACG | 433 | Kozak et.al.[ | |
| R | GCCGATCGCGTGAAGTTCCG | ||||
| F | CGGCATCGTCAACATAACCT | 721 | |||
| R | TGTGCGGATGAAGTCAGCTC | ||||
| F | CAACGGAAGTGGGCGTTGTGGA | 244 | |||
| R | GCTGCACCAATTCGCTGAACG | ||||
| Trimethoprim | F | TGGTAGCTATATCGAAGAATGGAGT | 425 | Grape et al.[ | |
| R | TATGTTAGAGGCGAAGTCTTGGGTA | ||||
| F | AGCTACTCTTTAAAGCCTTGACGTA | 341 | |||
| R | GTGTTGCTCAAAAACAACTTCG | ||||
| F | ACATTTGACTCTATGGGTGTTCTTC | 280 | |||
| R | AAAACTGTTCAAAAACCAAATTGAA | ||||
| Tetracyclines | F | GGCGGTCTTCTTCATCATGC | 502 | Kozak et.al.[ | |
| R | CGGCAGGCAGAGCAAGTAGA | ||||
| F | CGCCCAGTGCTGTTGTTGTC | 173 | |||
| R | CGCGTTGAGAAGCTGAGGTG | ||||
| F | GCTGTAGGCATAGGCTTGGT | 888 | |||
| R | GCCGGAAGCGAGAAGAATCA | ||||
| Class 1 integrase | F | GCCTTGCTGTTCTTCTACGG | 565 | Levesque, et al.[ | |
| R | GATGCCTGCTTGTTCTACGG | ||||
| Class 2 integrase | F | AAGCAGACTTGACCTGA | 565 | White, et al. 2001[ | |
| R | CACGGATATGCGACAAAAAGGT | ||||
| Class 1 integron cassette | F | GGCATCCAAGCAGCAAG | Variable | Levesque et al.[ | |
| R | AAGCAGACTTGACCTGA | ||||
| Class 2 integron cassette | F | CGGGATCCCGGACGGCATGCACGATTTGTA | Variable | White et al.[ | |
| R | GATGCCATCGCAAGTACGAG |